Table 2.

Exploratory correlations between change in %BDNF, β-OHB, and glucose.

	Study 1 (NW; n = 18)		Study 2 (OB; n = 12)
	Placebo	Ketone	Placebo	Ketone
β-OHB AUC (mM × 120 min)	−0.100 (−0.542, 0.385)	−0.027 (−0.488, 0.445)	0.073 (−0.551, 0.645)	0.456 (−0.159, 0.816)
Glucose AUC (mM × 120 min)	0.005 (−0.462, 0.471)	−0.028 (−0.489, 0.442)	0.191 (−0.462, 0.709)	0.448 (−0.169, 0.813)
Glucose iAUC (mM × 120 min)	−0.039 (−0.497, 0.435)	−0.048 (−0.504, 0.428)	0.085 (−0.543, 0.651)	0.759 (0.328, 0.923)*
	Study 1 and 2 Combined (n = 30)
	Placebo		Ketone
β-OHB AUC (mM × 120 min)	0.078 (−0.296, 0.432)		0.616 (0.329, 0.799)*
Glucose AUC (mM × 120 min)	0.372 (0.007, 0.0650)*		0.589 (0.290, 0.783)*
Glucose iAUC (mM × 120 min)	0.221 (−0.159, 0.543)		0.657 (0.389, 0.822)*

Data are: correlation coefficient (95% confidence interval).

^*Significant correlation, p < 0.05.